Showing results (201-210 of 298) with videos related to
Sort By:
Pageof 30
The Lancet. Global Health|February 23, 2020
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort studyJasper Tromp, Sahiddah Bamadhaj, John G F Cleland, et al.European Journal of Heart Failure|March 17, 2021
Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaireAlice Ravera, Bernadet T Santema, Iziah E Sama, et al.JACC. Heart Failure|April 11, 2021
Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HFJasper Tromp, Wouter Ouwerkerk, John G F Cleland, et al.JACC. Heart Failure|September 7, 2023
Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF RegistryJasper Tromp, Justin A Ezekowitz, Wouter Ouwerkerk, et al.The New England Journal of Medicine|December 3, 2015
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary SyndromeMarc A Pfeffer, Brian Claggett, Rafael Diaz, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 30, 2020
Remote monitoring of cardiac implanted electronic devices: legal requirements and ethical principles - ESC Regulatory Affairs Committee/EHRA joint task force reportJens Cosedis Nielsen, Josef Kautzner, Ruben Casado-Arroyo, et al.European Journal of Heart Failure|January 22, 2022
Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registryJasper Tromp, Joost C Beusekamp, Wouter Ouwerkerk, et al.Journal of Cachexia, Sarcopenia and Muscle|March 20, 2021
The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failurePaloma Pandhi, Koen W Streng, Stefan D Anker, et al.Lancet (London, England)|August 19, 2008
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trialJohannes F E Mann, Roland E Schmieder, Matthew McQueen, et al.American Heart Journal|August 25, 2015
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome modelsPrateeti Khazanie, Gretchen M Heizer, Vic Hasselblad, et al.Pageof 30